Recent study published in the New England Journal of Medicine shows the cardiovascular benefits of using Semaglutide (Wegovy) by cutting the absolute risk of heart disease and stroke by 1.5 per cent for people with cardiovascular disease risk but no diabetes. Although this does not sound like much, it does have a significant global population impact.

Your Calls and Comments:

• Treatment of celiac disease and alterations to diet. Are there any supplements that should be used?
• Parents want to know what to do for their son who may be experiencing side effects to a particular antipsychotic medication for the treatment of schizophrenia/psychosis
• Various types of meningitis and how they are transmitted
• Subsegmental atelectasis of the lung